Charter Venture Group - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $94,391.01 -3.72%
Ethereum $3,424.56 +1.23%
BNB $643.19 -2.60%
Optimism $2.26 +3.84%
Arbitrum $0.90 +5.95%
Solana $237.40 -6.19%
Polygon $0.55 -1.61%
Cosmos $8.00 -7.05%
Avalanche $41.61 +0.26%

Bitcoin $94,391.01 -3.72%
Ethereum $3,424.56 +1.23%
BNB $643.19 -2.60%
Optimism $2.26 +3.84%
Arbitrum $0.90 +5.95%
Solana $237.40 -6.19%
Polygon $0.55 -1.61%
Cosmos $8.00 -7.05%
Avalanche $41.61 +0.26%

Charter Venture Group

investment firm

Summary
Investments
Exits
Employees

About

Charter Venture Group is a private equity and venture capital firm that invests in the healthcare industry.

Houston,Texas,United States

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Investor Type: Venture Capital

Charter Venture Group is no longer operational

Investments

Number of Investments

Number of Lead Investments

9

1

Charter Venture Group has made 9 investments. Their most recent investment was on Dec 5, 2008, when Broncus Technologies raised $38M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 5, 2008 Broncus Technologies	Series G	$38M	Biotechnology	—
Mar 22, 2004 Restore Medical	Series C	$26.50M	Health Care	—
Aug 29, 2003 CymaBay Therapeutics	Series A	$27M	Biopharma	—
May 1, 2002 AtriCure	Series Unknown	$3.50M	Biotechnology	—
Apr 3, 2002 Broncus Technologies	Series D	$20M	Biotechnology	—

Show More

Employee Profiles

Number of Employee Profiles

1

Charter Venture Group has 1 current employee profiles, including Executive Bob Kondamoori

Executive

Exits

Charter Venture Group has had 5 exits. Charter Venture Group most notable exits include Broncus Technologies , Upwork

Date	Company Name	Exit Type	Industry
Sep 24, 2021	Broncus Technologies	IPO	Biotechnology	Detail
Oct 2, 2018	Upwork	IPO	Freelance	Detail
Jul 18, 2014	CymaBay Therapeutics	IPO	Biopharma	Detail
Apr 23, 2008	Restore Medical	M&A	Health Care	Detail
Aug 26, 2005	AtriCure	IPO	Biotechnology	Detail